Drug
Orm 12741
Orm 12741: highest development phase Phase 2, developed by Orion Corporation. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ORM-12741 NCT01324518 | Phase 2 | Alzheimer's Disease |
| ORM-12741 NCT02471196 | Phase 2 | Alzheimer's Disease |
| ORM-12741 NCT00829907 | Phase 1 | Healthy |
Latest
No recent events.
Follow Orm 12741 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.